tiprankstipranks
Advertisement
Advertisement

AURA Stock Latest News

Aura Biosciences Announces Results of 2026 Annual Meeting
Company AnnouncementsAura Biosciences Announces Results of 2026 Annual Meeting
1d ago
8K
AURA
Aura Biosciences completes enrollment in belzupacap sarotalocan trial
PremiumThe Fly
Aura Biosciences completes enrollment in belzupacap sarotalocan trial
12d ago
AURA
Aura Biosciences price target lowered to $17 from $26 at Leerink
PremiumThe Fly
Aura Biosciences price target lowered to $17 from $26 at Leerink
1M ago
AURA
Aura Biosciences reports Q1 results, appoints new CEO
PremiumCompany Announcements
Aura Biosciences reports Q1 results, appoints new CEO
1M ago
8K
AURA
Aura Biosciences Completes Major Underwritten Equity Financing
PremiumCompany Announcements
Aura Biosciences Completes Major Underwritten Equity Financing
1M ago
8K
AURA
Aura Biosciences Announces Stock Repurchase Agreement with Shareholder
PremiumCompany AnnouncementsAura Biosciences Announces Stock Repurchase Agreement with Shareholder
1M ago
8K
AURA
Aura Biosciences $260M Spot Secondary priced at $6.00
Premium
The Fly
Aura Biosciences $260M Spot Secondary priced at $6.00
1M ago
AURA
Aura Biosciences Advances CoMpass Phase 3 Trial Progress
Premium
Company Announcements
Aura Biosciences Advances CoMpass Phase 3 Trial Progress
1M ago
8K
AURA
Aura Biosciences announces common stock, pre-funded warrant offering
PremiumThe Fly
Aura Biosciences announces common stock, pre-funded warrant offering
1M ago
AURA
Aura Biosciences says Natalie Holles to succeed Elisabet de los Pinos as CEO
PremiumThe Fly
Aura Biosciences says Natalie Holles to succeed Elisabet de los Pinos as CEO
1M ago
AURA
Aura Biosciences price target raised to $15 from $13 at Evercore ISI
PremiumThe Fly
Aura Biosciences price target raised to $15 from $13 at Evercore ISI
2M ago
AURA
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
PremiumRatings
Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating
2M ago
AURA
Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
PremiumCompany AnnouncementsAura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline
2M ago
8K
AURA
Is AURA a Buy, Before Earnings?
Premium
Pre-Earnings
Is AURA a Buy, Before Earnings?
3M ago
AURA
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
Premium
Company Announcements
Aura Biosciences Expands Evidence With New Patient-Reported Outcome Study in Eye Cancer
4M ago
AURA
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
PremiumRatings
Innovative Approach and Promising Data Drive Buy Rating for Aura Biosciences
7M ago
AURA
Aura Biosciences re-initiated with an Outperform at Evercore ISI
PremiumThe Fly
Aura Biosciences re-initiated with an Outperform at Evercore ISI
7M ago
AURA
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
PremiumRatings
Buy Rating on Aura Biosciences Inc. Driven by Promising Pipeline and Strategic Expansion in Ocular Oncology
7M ago
AURA
Aura Biosciences Reports Q3 2025 Financial Results
PremiumCompany Announcements
Aura Biosciences Reports Q3 2025 Financial Results
7M ago
AURA
Positive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
PremiumRatingsPositive Outlook for Aura Biosciences Inc: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
7M ago
AURA
Aura Biosciences Inc: Strong Buy Rating Backed by Promising Clinical Progress and Strategic Oncology Expansion
Premium
Ratings
Aura Biosciences Inc: Strong Buy Rating Backed by Promising Clinical Progress and Strategic Oncology Expansion
7M ago
AURA
Aura Biosciences Reports Q3 2025 Financial Results
Premium
Company Announcements
Aura Biosciences Reports Q3 2025 Financial Results
7M ago
8K
AURA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >